Skip to content

Clinical trials

Phase 3 Hepatitis C trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: United Kingdom Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20081
20101
20119
201212
20132
20144
20155
20162
20174

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences11
Bristol-Myers Squibb8
AbbVie4
Janssen R&D Ireland4
Debiopharm International SA3
Janssen-Cilag International NV3
Boehringer Ingelheim2
Human Genome Sciences Inc.2
Kirby Institute2
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C44
Hepatitis C, Chronic14
Fibrosis6
Hepatitis4
Bronchiolitis Obliterans Syndrome2
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1
Hepatitis, Chronic1
Hepatitis, Viral, Human1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.